43% of Americans now use AI wellness tools

WHOOP has not resolved its July 2025 FDA warning letter over the daily systolic/diastolic blood pressure estimate — confirmed by a company health executive at STAT's Breakthrough Summit today; the January 2026 updated FDA wellness guidance conditionally permits BP estimates that are non-invasive and validated against clinical values, a compliance threshold WHOOP has not yet confirmed meeting (STAT).
Oura partnered with ResMed to route Ring users with elevated nighttime breathing disturbance signals into OSA screening, virtual provider access, and sleep education — timed to a striking data point: U.S. adult wearable sleep tracking jumped from 16% in 2025 to 53% in 2026, per a ResMed survey, with an estimated 80% of OSA patients still undiagnosed (HME Business).

Garmin Connect v5.25 (released May 20) contains screenlessDeviceCapable and LimitedUI handler strings, the strongest technical signal yet that CIRQA hardware is nearly ready; subscriber voucher codes being added for Connect+ users with 6+ months of continuous paid subscription indicate CIRQA will likely sit within the Connect+ ecosystem (the5krunner, Notebookcheck).
Notebookcheck concludes the ~$500 leaked price is likely a gray-market artifact and not official MSRP — but notes CIRQA's lack of a display confers no recording advantage over a smartwatch; the most defensible niches are kettlebell training and combat sports where a screen would be impractical (Notebookcheck).
Google Health Coach launched globally on May 19 built on Gemini AI, ingesting Fitbit/Pixel Watch data, medical records, labs, and manual logs at $9.99/month or $99/year; Garmin, WHOOP, and Oura support is listed as "coming soon" (Glossy). Mintel reports 43% of U.S. consumers used AI wellness tools in late 2025, more than double the 2024 figure.
WHOOP ranked #44 on CNBC's 2026 Disruptor 50 with disclosed figures: 2.5M members, 103% bookings growth to a $1.1B 2025 run rate, cash-flow positive, and ~8 app opens per day per user (CNBC).

Function Health raised a $298M Series B at a $2.5B valuation, part of a convergence Worth magazine frames as a self-assembled healthcare system — wearables, blood biomarker testing, longevity clinics, and supplement tracking operating outside insurance (Worth).
WHOOP Advanced Labs data finds 22% of "highly active" WHOOP members show signs of metabolic dysfunction and ~30% carry cardiometabolic risk factors undetected by traditional annual checkups.
The data integration layer is now contested by five platforms — Google Health, Perplexity Health, Apple Health+, ChatGPT Health, and Microsoft Copilot Health — each positioning to own the wearable-labs-telehealth stack as it converges.
Oura CEO Tom Hale told Bloomberg the company's goal is predicting heart attacks "years before they happen"; Cedars-Sinai cardiologist Dr. Joseph Schwab counters that "the bar for prediction is much higher" than data gathering, and most wearable data sits outside HIPAA protections governed by terms of service rather than the medical privacy law (Seattle Times).

Vielight received a $4.6M U.S. DoD grant to study intranasal-transcranial PBM (itPBM) for chronic mild TBI in service members, veterans, and first responders; seven peer-reviewed studies released simultaneously include fMRI evidence of cerebrospinal fluid flow changes post-treatment (a glymphatic modulation signal), a double-blind NCAA football study showing stabilized neuroinflammatory markers and preserved axonal integrity, and a long COVID cognitive pilot (GlobeNewswire). Vielight neurological devices are not FDA cleared or approved for any neurological condition.
A scoping review in Lasers in Medical Science (7 trials, n=297) found red light (633–670nm) improved burn scar pigmentation and thickness on the Vancouver Scar Scale, while NIR (808–830nm) reduced hypertrophic scar stiffness, pain, and itch across multiple surgical contexts (Medical Dialogues). A biphasic dose-response was documented — moderate fluences outperformed both low and high doses; rare blistering occurred at high fluences; no standardized protocol has been established.

A UC San Diego study (n=50, NPP – Digital Psychiatry and Neuroscience) used 2 weeks of smartwatch-collected HR, activity, mood, and lifestyle data to train a per-person ML model identifying each participant's top lifestyle trigger; six weeks of personalized video coaching produced a 55% rate of no longer meeting depression criteria vs. ~30% for standard interventions, with a 36% drop in anxiety and effects holding at 3-month follow-up (UC San Diego). Small sample; no RCT control arm.
Expert protocol synthesis confirms heat is the correct pre-sleep modality, not cold: intense cold plunge near bedtime can extend sleep-onset latency via norepinephrine-driven alertness (the same mechanism behind its post-workout focus effect); for recovery, cold after cool-down is most effective; consensus protocol: 10–15°C water, 2–4 sessions/week, up to 5–10 minutes with established tolerance (CNA Lifestyle).

Get Biohacking Therapies & Devices in your inbox